Stock listing
OTC:ULGX Urologix Stock
Follow Urologix into a list and get an email when it puts out news.
Share price · OTC:ULGX
$0.0001 USD 0.0000 (0.0%)
Close on Oct 23, 2026
- Day range
- $0.0001 – $0.0001 USDOct 23, 2026
- Market cap
- —Left out: too few shares trade to back it
- 52-week range
- $0.0001 – $0.0126 USDLowest and highest trades, Oct 24, 2025 – Oct 23, 2026
- Traded on an average day
- $0 USDMedian day 0 shares · 63 days with no trades · last 3 months, Jul 23, 2026 – Oct 23, 2026

Daily closes
Last 3 months, Jul 23, 2026 – Oct 23, 2026 · OTC:ULGX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 83,334 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 125 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 290 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 650 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 | |
| $0.0001 | 0.0000 | 0.0% | $0.0001 | $0.0001 | $0.0001 | 0 |
- Ticker
- OTC:ULGX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- OTC
- Currency
- USD
Latest news
Urologix on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 9 in all · newest Jul 9, 2015 · oldest 2014
- Decks
- 1 deck · latest Jun 13, 2012
Valuation
price Oct 23, 2026
- Enterprise value
- No market cap
- P/E
- No market cap
- EV/sales
- No market cap
- EV/EBITDA
- No market cap
- Price/book
- No market cap
- Gross margin
- No statements on 6ix yet
- Operating margin
- No statements on 6ix yet
- Net margin
- No statements on 6ix yet
- Debt to equity
- No statements on 6ix yet
- Beta vs S&P 500
- 0.00
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Dec 31, 2024 | Feb 7, 2025 | |
| Quarter to Sep 30, 2024 | Nov 18, 2024 | |
| Quarter to Jun 30, 2024 | Aug 21, 2024 | |
| Quarter to Mar 31, 2024 | May 15, 2024 | |
| Quarter to Dec 31, 2023 | Feb 9, 2024 | |
| Quarter to Sep 30, 2023 | Nov 1, 2023 | |
| Quarter to Jun 30, 2023 | Aug 23, 2023 | |
| Quarter to Mar 31, 2023 | May 10, 2023 | |
| Quarter to Dec 31, 2022 | Feb 3, 2023 | 0.0% |
| Quarter to Sep 30, 2022 | Nov 2, 2022 |
All 17 quarters
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Jun 30, 2022 | Aug 17, 2022 | |
| Quarter to Mar 31, 2022 | May 11, 2022 | +100.0% |
| Quarter to Dec 31, 2021 | Feb 4, 2022 | |
| Quarter to Sep 30, 2021 | Oct 27, 2021 | |
| Quarter to Jun 30, 2021 | Aug 18, 2021 | +22.0% |
| Quarter to Mar 31, 2021 | May 12, 2021 | −12.1% |
| Quarter to Dec 31, 2020 | Feb 5, 2021 | +1.2% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| IPO Roadshow (June 2012) | IPO roadshow | 24 slides | Jun 13, 2012 |
Financials
Annual, in USD
Income statement
| Line | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14.2M | 16.6M | 17.0M | 12.6M | 14.8M | 12.8M | 14.9M | 21.3M | 25.9M | 25.8M |
| Cost of revenue | 8.14M | 8.41M | 8.64M | 6.03M | 6.57M | 6.37M | 6.89M | 13.9M | 8.99M | 7.81M |
| Gross profit | 6.09M | 8.18M | 8.38M | 6.54M | 8.20M | 6.45M | 8.01M | 7.42M | 16.9M | 18.0M |
| Research and development | 1.63M | 2.27M | 2.19M | 2.24M | 1.83M | 2.36M | 2.78M | 3.03M | 2.99M | 3.07M |
| Selling, general and administrative | 2.30M | 2.52M | 3.39M | 7.90M | 10.4M | 10.9M | 14.5M | 14.1M | 15.9M | 14.7M |
| Operating income | -6.93M | -3.92M | -4.14M | -3.73M | -2.26M | -4.46M | -16.8M | -8.93M | 769.0K | 3.12M |
| Depreciation and amortization | 587.0K | 674.0K | 695.0K | 565.0K | 793.0K | 973.0K | 1.19M | 2.26M | 2.02M | 1.88M |
| EBITDA | -6.34M | -3.25M | -3.45M | -3.16M | -1.46M | -3.49M | -15.6M | -6.67M | 2.78M | 5.00M |
| Interest expense | 693.0K | 555.0K | 482.0K | 0 | 0 | 0 | 0 | 0 | 0 | 9.00K |
| Income before tax | -7.62M | -4.28M | -4.64M | -3.73M | -2.26M | -4.41M | -16.4M | -8.38M | 1.14M | 3.26M |
| Income tax | -16.0K | 14.0K | 55.0K | 8.00K | -88.0K | 7.00K | -1.50M | 4.86M | -4.35M | 424.0K |
| Net income | -7.61M | -4.29M | -4.70M | -3.73M | -2.17M | -4.42M | -14.9M | -13.2M | 5.49M | 2.84M |
| Earnings per share, basic | -0.36 | -0.21 | -0.32 | -0.26 | -0.15 | -0.31 | -1.04 | -0.92 | 0.38 | 0.19 |
Balance sheet
| Line | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 718.0K | 2.29M | 1.90M | 3.06M | 5.70M | 7.03M | 11.0M | 12.3M | 11.1M | 10.6M |
| Short-term investments | 171.0K | |||||||||
| Receivables | 1.50M | 2.13M | 2.13M | 1.36M | 1.38M | 1.50M | 1.77M | 4.07M | 5.23M | 4.24M |
| Inventory | 1.40M | 1.95M | 1.45M | 1.13M | 1.50M | 1.41M | 1.63M | 2.42M | 2.63M | 1.74M |
| Current assets | 3.68M | 6.50M | 5.77M | 5.79M | 8.72M | 10.0M | 14.6M | 18.8M | 20.1M | 17.0M |
| Property, plant and equipment | 471.0K | 735.0K | 862.0K | 861.0K | 1.01M | 1.41M | 2.01M | 2.33M | 2.90M | 2.45M |
| Goodwill | 3.04M | 3.12M | 10.2M | 10.2M | 10.2M | |||||
| Total assets | 5.67M | 12.5M | 12.7M | 6.76M | 10.2M | 12.1M | 17.5M | 32.7M | 43.9M | 39.1M |
| Accounts payable | 892.0K | 628.0K | 3.38M | 741.0K | 434.0K | 462.0K | 774.0K | 948.0K | 1.38M | 1.53M |
| Current liabilities | 4.29M | 2.64M | 7.29M | 1.76M | 2.00M | 2.06M | 3.29M | 2.71M | 3.17M | 3.83M |
| Long-term debt | 4.59M | 5.33M | ||||||||
| Total debt | 5.33M | 5.33M | ||||||||
| Total liabilities | 12.6M | 12.1M | 12.1M | 1.92M | 2.00M | 2.22M | 3.63M | 4.78M | 3.92M | 5.96M |
| Shareholders' equity | -6.98M | 420.0K | 626.0K | 4.85M | 8.21M | 9.93M | 13.8M | 27.9M | 40.0M | 33.1M |
| Shares outstanding | 21.2M | 20.7M | 14.7M | 14.6M | 14.5M | 14.4M | 14.3M | 14.3M | 14.4M | 14.8M |
Cash flow
| Line | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -1.53M | -1.96M | -713.0K | -2.37M | -1.25M | -3.92M | -1.04M | 1.50M | 1.17M | 2.92M |
| Capital spending | -42.0K | -79.0K | -57.0K | -272.0K | -85.0K | -86.0K | -213.0K | -312.0K | -953.0K | -91.0K |
| Free cash flow | -1.57M | -2.04M | -770.0K | -2.64M | -1.34M | -4.01M | -1.26M | 1.18M | 214.0K | 2.83M |
| Cash from investing | -42.0K | -1.48M | -565.0K | -275.0K | -85.0K | -86.0K | -213.0K | -312.0K | -781.0K | 2.19M |
| Cash from financing | 3.83M | 116.0K | 4.00K | 10.0K | 8.00K | 39.0K | 12.0K | 69.0K | 348.0K | |
| Share buybacks | 3.83M | 116.0K | 4.00K | |||||||
| Change in cash | -1.57M | 391.0K | -1.16M | -2.64M | -1.33M | -4.00M | -1.22M | 1.20M | 455.0K | 5.46M |
Cap table
Built by 6ix from Urologix’s releases
- Common shares
- 21,817,726
- Fully diluted
- 21,817,726
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 21,817,726 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 21,817,726 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Guy C Jackson Other companies: Cyberonics Inc (Director · Jun 18, 2007 – Oct 19, 2015 · Past); Life Time Fitness Inc (Director · May 4, 2006 – Jun 10, 2015 · Past); Digi International Inc. (Director · Jan 18, 2006 – Nov 24, 2015 · Past) | Director · Nov 7, 2006 – Nov 10, 2009 · Past |
| Patrick D Spangler Other companies: OptimizeRx Corporation (Director · Since at least Mar 23, 2018); Epocrates Inc (Chief Financial Officer · Feb 1, 2011 – Jan 20, 2012 · Past); ev3 Inc (Sr. VP and CFO · May 9, 2006 – Nov 15, 2008 · Past) | Director · Aug 15, 2010 – Nov 6, 2014 · Past |
| Sidney W Emery Jr Other companies: AIxCrypto Holdings, Inc. (Director · Dec 7, 2020 – Jul 11, 2022 · Past); Allete Inc (Director · May 8, 2007 – Jun 1, 2018 · Past); MTS Systems Corporation (Chairman, Director · Nov 22, 2005 – Jul 30, 2008 · Past) | Director · Feb 2, 2006 – Nov 19, 2014 · Past |
| Kirsten Doerfert Other companies: Axe Compute Inc. (VP of Sales and Marketing · Oct 19, 2009 – Oct 19, 2009 · Past) | Sr VP and Gen'l Mgr · Aug 23, 2007 – Oct 30, 2007 · Past |
| Brian J Smrdel | Chief Financial Officer · Aug 14, 2013 – Aug 14, 2013 · Past |
| Jerry C Cirino | Director · Jan 18, 2006 – Nov 11, 2008 · Past |
| Rebecca J Weber | Dir. of Finance & Controller · Apr 15, 2008 – Aug 6, 2009 · Past |
| Stryker Warren Jr | Chief Executive Officer, Director · Jun 24, 2008 – Jun 29, 2012 · Past |
Log in to ask 6ix AI your own questions about Urologix.